Our mission is to accelerate drug discovery and development from academia and industry with the infrastructure and expertise to generate, test, and validate new hypotheses driven by the rapidly evolving field of high-throughput discovery sciences.
Our core facility specializes in the discovery of probes and drugs, including small molecules, biologics, and cell therapies. We achieve this by adapting cellular and biochemical assays for high-throughput and high-content screening (HTS/HCS). Additionally, we excel in generating and printing complex organotypic three-dimensional (3D) disease models, such as organoids and tumor organoids derived from cell lines or patients, which are compatible with HTS/HCS. Our facility is equipped with state-of-the-art robotic automation (G3 Explorer) and integrated instrumentation from Revvity and other leading vendors.
Janus G3 Automated Liquid Handling Platform: Equipped with 96- and 384-channel MDTheads, an 8-channel Varispan, gripper tool, an integrated 70 tip box carousel, and a large deck size. The Janus G3 MDT heads are capable of dispensing and mixing precise volumes of diverse viscosities (0.5-200 µL) to 96-, 384-, and 1536-well plates in a single step. The 8-channel Varispan allows for rapid and precise dispensing of volumes (0.5 µL to 1 mL), generally, for cherry-picking, and drug dilution plate generation.High-Content Imaging and HTS Plate Reader:
Opera Phenix Plus High-Content Screening System: The Opera Phenix Plus is a true high-content imaging system that is equipped with 4 cameras for simultaneous image acquisition. Our system is configured with 4 excitation lasers (405, 488, 561, and 640) and 14 emission filters, enabling the acquisition of high-quality confocal images for all the most common fluorescent dyes. Additionally, the system is equipped with 5 objectives (5x air, 10x air, 20x air, 20x water, and 40x water). The Opera Phenix Plus software (Harmony 5.2) is fully automated and can be set up to acquire multiple fields of view, multiple Z-stacks, and partial or full plates from 6- to 1536-wells. For example, a 96-well plate with 3 fluorophores and 9 fields of view can be imaged in 15 minutes. In addition, the software enables cell segmentation, machine learning analysis, maximum projection, flat field correction, among other features that streamline image analysis.
Envision HTS Plate Reader:The Envision HTS is fully equipped for all leading detection modalities: Fluorescence, Luminescence, Absorbance, Fluorescence Polarization, AlphaScreen, and Homogeneous Time-Resolved Fluorescence (HTRF). The instrument is equipped with a barcode reader, high sensitivity cameras to enable quick plate reads (i.e. assays in 384-well format <1 min), monochromators, custom filter sets, bottom read capability, and temperature control.
Plate::handler™ Flex (PFlex): The PFlex is a robotic arm equipped with a gripper for plate handling. The arm moves on a vertical and horizontal rail system to two deck levels on the G3 Explorer system (HEPA filtered enclosure) to place plates in landscape or portrait mode on several instruments. The PFlex can access the following equipment within the G3 Explorer:
BIO CELLX: The BIO CELLX is a recently released fully automated and high throughput bioprinting instrument capable of dispensing droplets in desired patterns to generate complex 3D biostructures. Our core facility is currently developing protocols to validate drug screens and phenotypical analysis using the Envision HTS and Opera Phenix Plus. Our core facility seeks to meet the demands for the establishment of more in vivo representative cell models, and this newly acquired instrument will help us achieve that goal.

Dan LaBarbera, PhD
Professor and Director, the CU Anschutz Center for Drug Discovery
Email: [email protected]
Phone: 303-724-4116

Qiong Zhou, MS
D3SR Research Services Program Director
Email: [email protected]
Phone: 303-724-9278

Hector Esquer, PhD
Research Instructor and Automation Scientist
Email: [email protected]
Phone: 303-724-9278
To learn more visit the D3SR core facility links below and navigate to the D3SR iLabs website to request for consultation or drug discovery and development services.